NCT05736523View on ClinicalTrials.gov

Improving Early Detection of Melanoma Recurrence With Circulating Tumor DNA (ctDNA)

Active, not recruitingOBSERVATIONAL
Enrollment

28

Participants

Timeline

Start Date

September 23, 2020

Primary Completion Date

June 30, 2025

Study Completion Date

June 30, 2025

Conditions
Melanoma
Trial Locations (2)

84107

Intermountain Medical Center, Murray

84112

Huntsman Cancer Institute, Salt Lake City

Sponsors
All Listed Sponsors
collaborator

Intermountain Medical Center

OTHER

collaborator

Natera, Inc.

INDUSTRY

lead

University of Utah

OTHER